🟢 Marker Therapeutics is trading at 5.8% up in pre-market with no clear catalyst

Marker Therapeutics is trading 5.8% higher at $1.10 in pre-market, with the immediate catalyst unclear.

• Shares extended the October 16 advance, closing at $1.04 after a 13.04% gain; no October 19 announcement or fresh overnight catalyst appears in available investor-relations releases.
• A Zacks Strong Buy upgrade reported October 16 reflected rising earnings estimates but does not establish the reason for the move.
• Major U.S. indices are uneven and the biotech sector is down 3.65%; neither clearly explains the rise.